Completed

Investigation of the Effect of Pomegranate Supplementation on Symptom Severity in Women With Premenstrual Syndrome: A Randomized Controlled Trial

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

pomegranate extract

Dietary Supplement
Who is being recruted

Menstruation Disturbances+1

+ Pathologic Processes

+ Premenstrual Syndrome

From 18 to 49 Years
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: January 2024
See protocol details

Summary

Principal SponsorSakarya University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 2, 2024

Actual date on which the first participant was enrolled.

This study focuses on exploring how taking pomegranate supplements might help women who experience premenstrual syndrome (PMS), a common issue affecting many women of childbearing age. PMS can cause a variety of uncomfortable symptoms leading up to menstruation, and while some women manage these symptoms with medication, others look for natural alternatives due to medication side effects. Pomegranate is known for its rich antioxidant content and estrogen-like properties, which may help balance hormones and reduce the severity of PMS symptoms. By understanding how pomegranate can ease these symptoms, this study aims to offer a natural, potentially safer alternative to traditional medications. Participants in this study will take pomegranate supplements over an eight-week period. Researchers will monitor the severity of their PMS symptoms to see if there is any improvement. The study does not involve any invasive procedures, as pomegranate supplements are taken orally like regular vitamins. The goal is to evaluate whether the natural properties of pomegranate can effectively lessen the discomfort and distress caused by PMS, offering a more natural approach to managing these symptoms.

Official TitleInvestigation of the Effect of Pomegranate Supplementation on Symptom Severity in Women With Premenstrual Syndrome: A Randomized Controlled Trial
NCT06201702
Principal SponsorSakarya University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 49 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Menstruation DisturbancesPathologic ProcessesPremenstrual SyndromePathological Conditions, Signs and Symptoms

Criteria

Inclusion Criteria: Women who experience PMS complaints (those with a PMSS total score of more than 50%) and who volunteer to participate in the research will be included in our study. Exclusion Criteria: * History of acute or chronic illness or history of medication and supplement use * PMSS total score \<50% * Irregular menstrual cycle * History of allergy to herbal medicine * Experiencing any stressful event during the intervention

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Participants in the intervention group will first be pre-tested by filling out the data collection tools, and then they will be informed about 3 mL of pomegranate supplementation three times a day for 10 days during 2 menstrual cycles (between 7 days before and 3 days after the estimated onset of menstruation). The test will be repeated at the end of the 2nd month after the intervention

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Sakarya University

Sakarya, Turkey (Türkiye)Open Sakarya University in Google Maps
CompletedOne Study Center